Peptide-Based Nanoparticles Suppress Hepatic Inflammation via Blockage of Human Antigen R

Area of Science:

• Biochemistry
• Nanotechnology
• Molecular Biology

Background:

• Human antigen R (HuR) is an mRNA-binding protein regulating translation, with elevated expression linked to inflammation, cancer, and other diseases.
• HuR's role in disease pathogenesis makes it a significant therapeutic target.
• Developing targeted therapies to modulate HuR activity is crucial for disease treatment.

Purpose of the Study:

• To develop and evaluate a peptide-based nanoparticle (NP) system for targeting HuR.
• To investigate the anti-inflammatory potential of these NPs in ameliorating acute liver injury.
• To explore the therapeutic efficacy of HuR-targeting NPs in disease models.

Main Methods:

• Utilized molecular modeling to elucidate peptide-HuR interactions at the RNA-binding site.
• Engineered peptide-based NPs as nanocarriers for intracellular delivery.
• Assessed NP efficacy in vitro using activated macrophage cells and in vivo using a LPS/D-GalN-induced hepatic sepsis model.
• Evaluated effects on protein expression, cellular damage, and animal survival rates.

Main Results:

• Molecular modeling confirmed peptides bind to HuR's RNA-binding site via hydrogen-bonding and hydrophobic interactions.
• Peptide-based NPs successfully delivered peptides into cells, inhibiting HuR's mRNA binding.
• In vitro studies showed potent anti-inflammatory activity with no observed adverse effects.
• In vivo administration significantly reduced liver necrosis and HuR expression, improving survival in a sepsis model.

Conclusions:

• Peptide-based NPs offer a promising strategy for targeting HuR and its associated downstream signaling.
• This system demonstrates significant therapeutic potential for hepatic inflammation and other diseases characterized by HuR overexpression.
• The developed NPs provide a safe and effective platform for treating HuR-related pathologies.